SNORD86: A Potential Drug Target and Biomarker (G692201)

Target Name: SNORD86

NCBI ID: G692201

SNORD86

Other Name(s): small nucleolar RNA, C/D box 86 | U86 | Small nucleolar RNA, C/D box 86

SNORD86: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to help ensure the stability and translation of mRNAs into the cytoplasm, which are then targeted to the ribosome for protein synthesis. C/D box 86 (SNORD86) is a specific type of snRNA that is expressed in high levels in various tissues and cells, and it has been shown to play important roles in cellular processes such as cell growth, differentiation, and stress response.

Recent studies have identified SNORD86 as a potential drug target and biomarker, which may have implications for the development of new therapeutic strategies for various diseases. In this article, we will explore the biology of SNORD86 and its potential as a drug target and biomarker.

The Biology of SNORD86

SNORD86 is a 24-nt RNA molecule that contains a characteristic C/D box shape and is expressed in various tissues and cells, including the brain, heart, liver, and muscle. It is one of the most abundant snRNAs in the brain and has has been shown to be involved in the regulation of protein synthesis, cell growth, and stress response.

SNORD86 has been shown to play a critical role in the regulation of protein synthesis, particularly in the translation of pre-mRNA to protein. It has been shown to interact with the protein translated from mRNA, which may help to ensure its stability and proper localization to different cellular compartments.

SNORD86 is also involved in the regulation of cell growth and differentiation. It has been shown to play a role in the regulation of cell proliferation and the establishment of cell lineage. Additionally, it has been shown to be involved in the regulation of cell survival in response to stress, such as stress caused by lack of oxygen or exposure to toxins.

SNORD86 has also been shown to play a role in the regulation of gene expression. It has been shown to interact with various proteins, including the transcription factors RNA polymerase II (RNA-P2) andCREB-p200, which may help to regulate the translation of gene expression.

Potential drug targets and biomarkers

The potential use of SNORD86 as a drug target or biomarker makes it an attractive target for the development of new therapeutic strategies for various diseases. Here are a few examples of how SNORD86 may be used as a drug target or biomarker:

1. SNORD86 as a drug target: SNORD86 has been shown to play a critical role in the regulation of protein synthesis, which may make it an attractive target for small molecule inhibitors that target this pathway. For example, inhibitors of the protein translated from SNORD86 have been shown to be effective in treating various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.
2. SNORD86 as a biomarker: SNORD86 has been shown to play a critical role in the regulation of gene expression, which may make it an attractive biomarker for a variety of diseases. For example, changes in the levels of SNORD86 have been shown to be associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Additionally, changes in SNORD86 levels have been shown to be associated with certain medications, such as chemotherapy drugs, which may be used as a biomarker for monitoring the effectiveness of these medications.

Conclusion

SNORD86 is a small nucleolar RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. Its potential as a drug target and biomarker makes it an attractive target for the development of new therapeutic strategies for various diseases. Further research is needed to fully understand the biology of SNORD86 and its potential as a drug

Protein Name: Small Nucleolar RNA, C/D Box 86

The "SNORD86 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD86 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets